As of July 31, 2008 the Company had 5,300 employees compared to 3,705 employees on December 31, 2007.
Business Outlook for Full Year 2008
In May 2008, Mindray completed its acquisition of the patient monitoring business of Datascope Corporation (Nasdaq: DSCP) for approximately $209 million in cash (the the "transaction"). Upon completion of this transaction, Mindray became the third-largest player in the global patient monitoring device industry furthering Mindray's goal of becoming a leading provider of high-quality medical devices to markets worldwide. After closing of the transaction, the Company maintains its full-year 2008 net revenue guidance to be in the range of US$560 million to US$580 million, including the consolidation of Datascope's patient monitoring business starting from May 1, 2008.
The updated full-year 2008 non-GAAP (excluding share-based compensation expenses and amortization of intangible assets resulting from acquisitions) net income guidance will be in the range of US$132 million to US$135 million, taking into consideration a 15% effective income tax rate after certain government tax incentives and rebates.
Non-GAAP EPS is expected to be in the range of US$1.16 to US$1.18 per fully diluted share based on an estimated average diluted share count of 114 million for the year. The Company expects DPM acquisition to yield a neutral impact to its 2008 non-GAAP EPS.
In accordance with SFAS No. 123R, the Company estimates total
share-based compensation expenses in 2008 will be approximately US$10
million based on employee share options that have been granted as of June
30, 2008. The Company expects approximately US$16.1 million in
|SOURCE Mindray Medical International Limited|
Copyright©2008 PR Newswire.
All rights reserved